Eli Lilly’s LLY extraordinary revenue expansion remains anchored in its cardiometabolic franchise, where blockbuster GLP-1 drugs Mounjaro and Zepbound powered $20.6 billion in sales during

Popular GLP-1 weight-loss injections like Ozempic or WeGovy are now delivering greater value, according to a new report

Plus, news about Anavex, Alnylam, Rapport Therapeutics, Dianthus Therapeutics, Ultragenyx, Atom Therapeutics, Alchemab, BioMarin, Amgen, Kyowa Kirin and Bristol Myers Squibb: 🤧 Regeneron’s allergy drugs

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s STAT’s

By Deena Beasley(Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more…

Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers.

Healthcare, Vol. 13, Pages 2259: Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025) Healthcare doi: 10.3390/healthcare13182259 Authors: Hadi A. Almansour Hilal

Greggs‘ (LSE:GRG) shares have lost around half of their value over the past 12 months. And I think thatâs probably fair. I thought the stock

The Food and Drug Administration recently announced new measures to prevent the import of dangerous foreign counterfeits of GLP-1 drug ingredients, which are being used

Idiopathic intracranial hypertension (IIH) is a disorder of elevated intracranial pressure (ICP) of unknown cause that primarily affects young women with obesity. Although the symptoms

This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is

Key Points Dividend Aristocrat stocks may be about to enter a very favorable environment this month. The following three have some of the strongest underlying

For the first time, the World Health Organization has named popular GLP-1 weight loss drugs as essential medicines, a move set to reshape access to

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines,

The World Health Organization has updated its model lists of essential medicines (EML), adding 20 new treatments for a range of conditions, including a controversial

Semaglutide and other GLP-1 receptor agonists show robust benefit in polycythemia vera, but it’s unclear whether this is due to anticancer effects or simple weight

Biomedicines, Vol. 13, Pages 2192: Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo Biomedicines doi: 10.3390/biomedicines13092192 Authors: Inderjeet Singh

GLP-1 MANIA: People used to tell me I had a pretty face. I thought GLP-1 would make my body hot too — but it did

Hello, I went on wegovy using shemed, and although they have provided me with a nice diet plan, I think there are some supplements that

The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the country

Shares of Eli Lilly & Co. and Novo Nordisk A/S fell after US regulators established a “green list” of foreign manufacturers who produce raw materials

Please enjoy this transcript of my interview with Dr. Dominic D’Agostino (@DominicDAgosti2), a tenured associate professor in the Department of Molecular Pharmacology and Physiology at

The Vishwa Swasthya Sangathan has included GLP-1 drugs for diabetes in its essential medicines list. This move aims to enhance global access to these costly

The U.S. Food and Drug Administration is tightening oversight of imports of GLP-1 drug ingredients, used for weight loss and diabetes, amid concerns that many

The Inclusion of the weight loss medicine to the list should boost access to the drugs in poorer countries

The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said

Between 2016 and 2022, the rate of US adults with type 2 diabetes who used glucagon-like peptide-1 (GLP-1) receptor agonists rose from about 4% to

It’s not exactly news that Ozempic, Wegovy and other GLP-1 drugs are catching on, with some surveys showing nearly 12% of Americans have used the

UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries.

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

(Reuters) -The U.S. Food and Drug Administration sent an import alert on Friday to help stop illegal imports of GLP-1 drug ingredients entering the…

Post Content

Biomedicines, Vol. 13, Pages 2174: Translating Guidelines into Practice: A Prospective Real-World Study of a Romanian Cohort Treated with GLP-1 RAs Biomedicines doi: 10.3390/biomedicines13092174 Authors:

The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said

Find out more about recent trends in China’s infant formula sales, eye health supplement ingredients, and biotics for GLP-1 in this round-up.

Explore how GLP-1 therapies, beyond weight loss and diabetes care, may influence male fertility by improving hormonal balance, metabolism, and reproductive health outcomes.

(MedPage Today) — HOUSTON — Patients with polycythemia vera (PV) and a history of treatment with GLP-1 agonists had significantly lower rates of multiple adverse